Locations:
SearchAdvertisement
Limited data and experience will translate to a cautious rollout
Investigators conclude that improved self-reports go beyond possible placebo effect for severe TR
TEER is found to be a safe and good option for severe TR in select patients
New study illuminates mechanical underpinnings of secondary leaks
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
FDA-designated breakthrough device offers first treatment option for severe TR and right HF
Also, earlier surgery likely benefits patients with severe functional TR
Concomitant repair is a trade-off if tricuspid regurgitation is less than severe
Companion study shows apparent benefit from surgery in both primary and secondary TR
Advertisement
Advertisement